Literature DB >> 1346567

Investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro.

M O McClure1, J P Moore, D F Blanc, P Scotting, G M Cook, R J Keynes, J N Weber, D Davies, R A Weiss.   

Abstract

Sulfated polysaccharides have been shown to inhibit human immunodeficiency virus (HIV) infection in vitro. Dextrin sulfate, fucoidan, and dextran sulfate fail to neutralize virions directly, but interact with target cells to inhibit virus entry. Ionic interactions of sulfated polyanions with oppositely charged cell surface components, including CD4, have been assumed to be the inhibitory mechanism. It is shown that the sulfated polysaccharides inhibit infection of both CD4+ and CD4- cell lines by HIV and also that they inhibit HTLV-1 and, to a lesser extent, the simian retrovirus, MPMV, which use receptors other than CD4. One binding site for radiolabeled fucoidan on the surface of human T cells is an 18 kD protein, but its significance is not yet clear.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1346567     DOI: 10.1089/aid.1992.8.19

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  36 in total

1.  An Update on Vaginal Microbicides.

Authors:  Christine Mauck; Gustavo Doncel
Journal:  Curr Infect Dis Rep       Date:  2001-12       Impact factor: 3.725

2.  A comparative study of the specificity of fucoidanases of marine microorganisms and invertebrates.

Authors:  M I Kusaikin; A O Chizhov; S A Alekseeva; I Yu Bakunina; O I Nedashkovskaya; V V Sova; T N Zvyagintseva; G B Elyakov
Journal:  Dokl Biochem Biophys       Date:  2004 May-Jun       Impact factor: 0.788

3.  Endo-fucoidan hydrolases from glycoside hydrolase family 107 (GH107) display structural and mechanistic similarities to α-l-fucosidases from GH29.

Authors:  Chelsea Vickers; Feng Liu; Kento Abe; Orly Salama-Alber; Meredith Jenkins; Christopher M K Springate; John E Burke; Stephen G Withers; Alisdair B Boraston
Journal:  J Biol Chem       Date:  2018-10-03       Impact factor: 5.157

Review 4.  The potential for heparin and its derivatives in the therapy and prevention of HIV-1 infection.

Authors:  C C Rider
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

5.  Structural characteristics and in vitro macrophage activation of acetyl fucoidan from Cladosiphon okamuranus.

Authors:  Takeshi Teruya; Hideki Tatemoto; Teruko Konishi; Masakuni Tako
Journal:  Glycoconj J       Date:  2009-11       Impact factor: 2.916

6.  A styrene-alt-maleic acid copolymer is an effective inhibitor of R5 and X4 human immunodeficiency virus type 1 infection.

Authors:  Vanessa Pirrone; Shendra Passic; Brian Wigdahl; Robert F Rando; Mohamed Labib; Fred C Krebs
Journal:  J Biomed Biotechnol       Date:  2010-05-31

7.  Structure-function relations of heparin-mimetic sulfated xylan oligosaccharides: inhibition of human immunodeficiency virus-1 infectivity in vitro.

Authors:  A L Stone; D J Melton; M S Lewis
Journal:  Glycoconj J       Date:  1998-07       Impact factor: 2.916

8.  Influence of host cell type and V3 loop of the surface glycoprotein on susceptibility of human immunodeficiency virus type 1 to polyanion compounds.

Authors:  P R Meylan; R S Kornbluth; I Zbinden; D D Richman
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

Review 9.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

10.  Anti-human immunodeficiency virus type 1 activity of an oligocationic compound mediated via gp120 V3 interactions.

Authors:  W A O'Brien; M Sumner-Smith; S H Mao; S Sadeghi; J Q Zhao; I S Chen
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.